Home → Releases → 2015, №4 (20) →

Activity of Peptidyl-dipeptidase A in the Brain Regions of Rats after a Single Administration of Fluoxetine

Earth Sciences and Natural Sciences

Authors

  • Kruchinina Anastasia Dmitriyevna Postgraduate, assistant, General Biology and Biochemistry department, Penza State University. E-mail: a.d.kruchinina@mail.ru
Tags:
Depression. , Fluoxetine , Peptidyl-dipeptidase A , Regulatory peptides , Серотонин

How to link insert

Kruchinina, A. D. (2015). Activity of Peptidyl-dipeptidase A in the Brain Regions of Rats after a Single Administration of Fluoxetine Bulletin of the Moscow City Pedagogical University. Series "Pedagogy and Psychology", 2015, №4 (20),
References
1. Eliseev U.U. Psixosomaticheskie zabolevaniya. Polnij spravochnik. М.: E'xmo,
2. 608 s.
3. Lakin G.F. Biometriya. М.: Vischaya shkola, 1990. 352 s.
4. Mosolov S.N.Sovremennie biologicheskie gipotezi rekkurentnoj depressii (obzor) // Zhurnal nevrologii i psixiatrii. 2012. Т. 11. № 2. S. 29-40.
5. Solov'ew V.B., Gengin М.Т. Aktivnost' peptidildipeptidazy' A i carboksipeptida-zy' N v sy'vorotke krovi pacientov s bolezn'yu Al'czgejmera // Ukr. bioxim. zhurn. 2007. Т. 79. № 6. С. 106-108.
6. Baghai T.C., Binder E.B., Schule C., Salyakina D., Eser D., Lucae S., Zwanzger P., Haberger C., Zill P., IsingM., Deiml T., Uhr M., Illig T., Wichmann H.E., Modell S., Nothdurf-ter C., Holsboer F., Müller-Myhsok B.,. Möller H.J, Rupprecht R., Bondy B. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activi­ty and hypercortisolism // Mol Psychiatry. 2006. V. 11. № 11. P. 1003-1015.
7. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease //
8. Clin Chem Lab Med. 2002. V. 40. № 3. P. 256-265.
9. Castren E. Is mood chemistry? // Nat Rev Neurosci. 2005. V. 6. № 3. P. 241-246.
10. Gomez F., Venero C., Viveros M.P., Garcia-Garcia L. Short-term fluoxetine treat­ment induces neuroendocrine and behavioral anxiogenic-like responses in adolescent male
11. rats // Exp Brain Res. 2015. V. 233. № 3. P. 983-995.
12. Guo F., Chen X.L., Wang F., Liang X., Sun Y.X., Wang Y.J. Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages // Interferon Cytokine Res. 2011. V. 31. № 4. P. 351-361.
13. Hirschfeld R.M. History and evolution of the monoamine hypothesis of depres­sion // J Clin Psychiatry. 2000. V. 61. № 6. P. 4-6.
14. Humble M. Noradrenaline and serotonin reuptake inhibition as clinical prin­ciples: a review of antidepressant efficacy // Acta Psychiatr Scand Suppl. 2000. V. 402.
15. P. 28-36.
16. Kormos V, Gaszner B. Role of neuropeptides in anxiety, stress, and depression: from animals to humans // Neuropeptides. 2013. V. 47. № 6. P. 401-419.
17. Lowry O.H., Rosebrought N.J., Farr A.G., Randall R.J. Protein measurement with the Folin phenol reagent // J. Biol. Chem. 1951. Vol. 193. № 1. Р. 265-275.
18. Reis W.L., Giusti-Paiva A., Ventura R.R., Margatho L.O., Gomes D.A., Elias L.L., Antunes-Rodrigues J. Central nitric oxide blocks vasopressin, oxytocin and atrial natriure-
19. tic peptide release and antidiuretic and natriuretic responses induced by central angioten­sin II in conscious rats // Exp Physiol. 2007. V. 92. № 5. P. 903-911.
20. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression // Prog Neuropsychopharmacol Biol Psychiatry. 2005. V. 29. № 2. P. 201-217.
21. Taylor W.D, Aizenstein H.J., Alexopoulos G.S. The Vascular Depression Hypo­thesis: Mechanisms Linking Vascular Disease with Depression // Mol Psychiatry. 2013. V. 18. № 9. P. 963-974.
22. Valera E., Ubhi K., Mante M., Rockenstein E., Masliah E. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy // Glia. 2014. V. 62. № 2. P. 317-337.
23. Ventura-Junca R., Symon A., Lopez P., Fiedler J.L., Rojas G., Heskia C., Lara P., Marin F., Guajardo V., Araya A.V., Sasso J., Herrera L. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and luoxetine in patients with major depressive disorder: a prospective study // BMC Psychiatry. 2014. V. 14. P. 220.
Download file .pdf 349.5 kb